JP2024020436A5 - - Google Patents

Download PDF

Info

Publication number
JP2024020436A5
JP2024020436A5 JP2023195187A JP2023195187A JP2024020436A5 JP 2024020436 A5 JP2024020436 A5 JP 2024020436A5 JP 2023195187 A JP2023195187 A JP 2023195187A JP 2023195187 A JP2023195187 A JP 2023195187A JP 2024020436 A5 JP2024020436 A5 JP 2024020436A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023195187A
Other versions
JP2024020436A (ja
Filing date
Publication date
Priority claimed from JP2022565479A external-priority patent/JP7393774B2/ja
Application filed filed Critical
Publication of JP2024020436A publication Critical patent/JP2024020436A/ja
Publication of JP2024020436A5 publication Critical patent/JP2024020436A5/ja
Pending legal-status Critical Current

Links

JP2023195187A 2020-11-30 2023-11-16 Her2標的化剤 Pending JP2024020436A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2020198044 2020-11-30
JP2020198044 2020-11-30
JP2021110912 2021-07-02
JP2021110912 2021-07-02
JP2022565479A JP7393774B2 (ja) 2020-11-30 2021-11-29 Her2標的化剤
PCT/JP2021/043538 WO2022114163A1 (ja) 2020-11-30 2021-11-29 Her2標的化剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022565479A Division JP7393774B2 (ja) 2020-11-30 2021-11-29 Her2標的化剤

Publications (2)

Publication Number Publication Date
JP2024020436A JP2024020436A (ja) 2024-02-14
JP2024020436A5 true JP2024020436A5 (ja) 2024-05-23

Family

ID=81754499

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022565479A Active JP7393774B2 (ja) 2020-11-30 2021-11-29 Her2標的化剤
JP2023195187A Pending JP2024020436A (ja) 2020-11-30 2023-11-16 Her2標的化剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022565479A Active JP7393774B2 (ja) 2020-11-30 2021-11-29 Her2標的化剤

Country Status (10)

Country Link
US (2) US20240002531A1 (ja)
EP (1) EP4253420A1 (ja)
JP (2) JP7393774B2 (ja)
KR (1) KR20230114747A (ja)
AU (1) AU2021387127A1 (ja)
CA (1) CA3199473A1 (ja)
IL (1) IL303154A (ja)
MX (1) MX2023005864A (ja)
TW (1) TW202229359A (ja)
WO (1) WO2022114163A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023196994A1 (en) * 2022-04-08 2023-10-12 Fate Therapeutics, Inc. Cells having solid tumor targeting backbone and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001294198C1 (en) 2000-10-06 2019-04-04 Kyowa Kirin Co., Ltd. Cells producing antibody compositions
ES2527143T3 (es) * 2009-12-07 2015-01-20 Fundació Privada Institució Catalana De Recerca I Estudis Avançants Anticuerpos frente a variante truncada CTF-611 de HER2
WO2012047427A2 (en) * 2010-08-31 2012-04-12 The Regents Of The University Of California Antibodies for botulinum neurotoxins
US11851479B2 (en) * 2018-06-18 2023-12-26 Dxdiscovery, Inc. Methods and compositions for pertussis diagnosis

Similar Documents

Publication Publication Date Title
BR102023012440A2 (ja)
BR102023010976A2 (ja)
BR102023009641A2 (ja)
BR102023008688A2 (ja)
BR102023007252A2 (ja)
BR102023005164A2 (ja)
BR102023001987A2 (ja)
BR102023001877A2 (ja)
BR102023000289A2 (ja)
BR102022026909A2 (ja)
BR102022023461A2 (ja)
BR202022009269U2 (ja)
BR202022005961U2 (ja)
BR202022001779U2 (ja)
BR202022000931U2 (ja)
BY13144U (ja)
BY13153U (ja)
BY13137U (ja)
BY13138U (ja)
BY13139U (ja)
BY13140U (ja)
BY13141U (ja)
BY13142U (ja)
BY13143U (ja)
BY13135U (ja)